Torsemide + Spironolactone

Torsemide + Spironolactone

Categories : Cardiovascular System

Product Packaging : 10 / 30 tablets

Product Composition : 10 mg + 50 mg

Send Message

Torsemide 10 mg + Spironolactone 50 mg Tablets are a combination diuretic therapy designed for management of edema, hypertension, and heart failure. Torsemide acts as a loop diuretic, promoting rapid fluid excretion, while Spironolactone is a potassium-sparing diuretic that helps maintain electrolyte balance. This synergistic combination ensures effective fluid reduction with minimized potassium loss.

Genliva Wellness LLP is a trusted Torsemide + Spironolactone Tablets manufacturer in India, providing GMP-compliant, high-quality cardiovascular formulations. The company is also a leading exporter and contract manufacturer, offering bulk supply, private-label production, and globally compliant tablets for hospitals, clinics, and distributors.

Torsemide and spironolactone tablets combine a loop diuretic with a potassium-sparing diuretic to provide balanced fluid management and electrolyte support. The formulation helps reduce excess fluid accumulation while minimizing potassium loss during therapy.

  • Dual diuretic combination for enhanced fluid control
  • Torsemide promotes effective removal of excess sodium and water
  • Spironolactone helps conserve potassium levels
  • Supports management of edema and fluid overload conditions
  • Provides complementary mechanism for improved therapeutic balance
  • Designed for consistent and reliable oral therapy

This combination is used in conditions involving fluid retention and cardiovascular imbalance where combined diuretic action is beneficial.

  • Congestive heart failure with edema
  • Fluid retention associated with liver disorders
  • Renal edema and fluid overload
  • Hypertension requiring combination diuretic therapy
  • Ascites management in chronic liver disease

The formulation offers effective diuresis with potassium-sparing support, helping improve long-term fluid management and patient stability.

  • Reduces risk of potassium depletion during diuretic therapy
  • Provides stronger and balanced edema control
  • Supports cardiovascular and renal fluid regulation
  • Suitable for chronic fluid retention management
  • Convenient combination therapy improves treatment adherence
  • Reliable formulation for routine clinical use

whatsapp-app